|
Daynes, R.A. Woodward, J.G., and Spellman, C.W. 1977. Immunoregulation by ultraviolet light. In: Proceedings 11th Leukocyte Culture Conference. (D.O. Lucas, Ed.) Academic Press, Inc., New York, p. 713.
Daynes, R.A. Spellman, C.W., and Woodward, J.G, 1977. Studies into the transplantation biology of ultraviolet light-induced tumors. Transplantation 23:343.
Daynes, R.A and Spellman CW. 1977. Evidence for the generation of suppressor cells by ultraviolet radion. Cell. Immunol 31: 182.
Spellman, CW and Daynes RA 1977. Modification of immunologic potential by ultraviolet radiation. Transplantaion 24:112.
Eichwald, EJ, Craven CM and Spellman CW 1977. The cell type mediating hyperacute rejection of allogeneic mouse skin grafts. Cell. Immunol. 33: 219.
Spellman, CW and Daynes, RA 1978. Properties of ultraviolet light induced suppressor lymphocytes within a syngeneic tumor system. Cell. Immunol 36: 383.
Spellman, CW and Daynes RA 1978. Ultraviolet light induced murine suppressor lymphocytes dictate specificity of anti-UV tumor immune responses. Cell. Immuno. 38:25.
Daynes, RA, Schmitt, MK, Roberts, LK, and Spellman, CW 1979. Phenotypic and physical characteristics of the lymphoid cells involved in the immunity to syngeneic UV induced tumors. J. Immunol. 122:2458.
Warner, NL, Daley, M, Richey J and Spellman CW 1979. Flow cytometry analysis of murine B cell lymphoma differentiation, Immunol. Rev 48:197.
Warner NL, Georgi JV, Burchiel SW and Spellman CW. 1979. Genetic aspects of tumor-host immune relationships. Current Can. Res. 234:5.
Roberts LK, Spellman CW and Daynes RA1980. Effector and suppressor T cell responses to primary and transplanted syngeneic tumors. J. Immunol. 125:663.
Spellman CW and Warner NL 1980. Correlations of MLR response with quantitative measurements of la expression on tumor stimulator cells. Fed. Proc. 39:686.
Spellman CW 1981. Ultraviolet light tumors and suppressor cells. Human Path. 12:489.
Roberts LK, Spellman CW, Georgi JV, Tai A, and Warner NL 1982. Characterization of a series of tumor reactive continous cell lines. In: Progress in Cancer Res. and Therapy. Raven Press, New York, 22: 207.
Spellman CW and Anderson RE 1982. Low dose radiosensitivity of alloimmune cytotoxic T cell. J. Exp. Med 155:1858.
Spellman CW and Tomasi TB 1983. Ultraviolet light induced suppression of antigen presentation. J. Clin. Immunol 3:105.
Spellman CW and Daynes RA 1983. Cross reactive antigenicity between UV irradiated skin and UV induced tumors. In: Effects of ultraviolet light on the immune system (J. Parrish, Ed) Johnson and Johnson Press. New Jersey p. 245.
Roberts LK and Spellman CW 1983. The functional properties of a UV-induced continious T-suppressor cell line with tumor specificity. In: Effects of UV light on the immune system. (J Parrish, Ed) Johnson and Johnson Press, New Jersey, p. 229.
Roberts LK, Spellman CW and Warner NL 1983. Establishment of a continuous T cell line capable of suppressing anti-tumor immune responses in vivo. J. Immunol. 131:514.
Spellman CW and Roberts LK 1983. Induction of suppressor T cells following UVL exposure of animals and their role in the regulation of immune responses to developing tumors. In: Experimental and Clinical Photoimmunology (RA Daynes and G Krueger, Eds) CRC Press, Inc. Vol 2, p 7.
Spellman CW, Bernhard EJ, Anderson WL and Tomasi TB 1983. Induction of systemic tolerance to antibody by contact sensitization through an ultraviolet light irradiated skin site. Fed. Proc. 42: 837.
Sibbit, WL, Likar L, Spellman CW, and Bankhurst AD 1983. Impaired natural killer cell function in systemic lupus erythematousus: Relationships to interleukin-2 production. Arthritis & Rheumatol. 26:1316.
Tomasi TB, Spellman CW and Anderson WL 1984. Clinically applicable procedures for producing tolerance to foreign protein antigens. In: Radioimmunoimaging and radioimmunotherapy. (BA Rhodes, Ed) Elsevier Science Publishing Company, p. 63.
Spellman CW and Daynes RA 1984. Cross reactive transplantation antigens between HIV irradiated skin and UV induced tumors. Photodermatol. 1:164.
Spellman CW, Anderson WL and Tomasi TB 1984. Suppression of antibody responses to topically applied antigens by ultraviolet light irradiation. Induction of phototolerance, J. Exp. Med. 160:1891.
Sibbit, WL, Kenny C, Spellman CW, Ley KD and Bankhurst AD 1984. Lymphokines in autoimmunity: Relationship between IL-2 and IF-gamma production in systemic lupus erythematosus. Clin. Immunol. Immunopath. 32:166.
Spellman CW, Anderson WL and Tomasi TB 1985. The role of UV exposure in the induction of experimental tolerance to topically applied agents. (RA Daynes and G. Krueger, Eds) CRC Press, Inc. Vol 3, p. 127.
Daynes, RA, Roberts LK and Spellman CW 1986. Immunologic aspects of experimental UVR carcinogenesis. Fed. Proc.
Anderson RE, Williams WL, Tokuda S and Spellman CW 1986. Low dose irraditation permits immunization of A/J mice with subimmunogenic numbers of SA 1 cells. British J. Can, 54:505.
Ming R, Atlura D, and Spellman CW 1987. Peripheral blood mononuclear cells, interleukin 2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease. J. Clin. Immunol. 7:59.
Bleicher JM, Gratch JO and Spellman CW 1991. Management of oliguria. Osteopathic Medical News 8(1):1.
Spellman CW, Matty K, and Weis SE 1998. A survey of drug-reistant mycobacterium tuberculosis and its relationship to HIV infection. AIDS 12:191-195.
Spellman CW Nov. 1999. Type 2 Diabetes: A new problem emerging in children. Texas D.O. 7-8.
Spellman CW 2003. Combination therapy for dyslipidemia. JAOA (Jan) 103:S 9-11.
Spellman CW 2003. Strategies for optimizing lipid treatment outcomes. JAOA, (Jan) 103:S 12-15.
Spellman CW 2003. Management of Diabetes in the Real World: Tight Control of Glucose Metabolism. JAOA (Aug) 103:S8-13.
Urrutia-Rojas X, Wadley W, Menchaca J, Ahmad N, Lacko A, Bae S, Spellman CW, et.al. 2004. Cardiovascular risk factors in Mexican-American school-age children at risk for Type 2 diabetes mellitus (T2DM), J. Adolescent Medicine 34:290-299.
Spellman, CW, Renda SM, Davis SN. 2005. Realizing the potential of Insulin Therapy in Type 2 Diabetes. A monograph, ACOI 64th Annual Clin. Sci. Symp. Chicago, IL.
Urrutia-Rojas X, McConathy WJ, Menchaca J, Spellman CW, Kudchodkar BJ, Lacko AG, Bae S. Overweight, and risk for type 2 diabetes mellitus and cardiovascular disease in Hispanic children. Health Education Monograph Series 2005;22(1):44-50.
Garcia P, Spellman CW 2006. Should all Diabetic Patients Receive Statins? Current Atherosclerosis Reports 8:12-18. |
